SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-030049
Filing Date
2021-03-01
Accepted
2021-03-01 16:37:16
Documents
14
Period of Report
2021-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm218312d1_8k.htm   iXBRL 8-K 25869
2 EXHIBIT 99.1 tm218312d1_ex99-1.htm EX-99.1 68583
6 GRAPHIC tm218312d1_ex99-1img001.jpg GRAPHIC 6175
  Complete submission text file 0001104659-21-030049.txt   286241

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA idra-20210301.xsd EX-101.SCH 3196
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE idra-20210301_lab.xml EX-101.LAB 34592
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE idra-20210301_pre.xml EX-101.PRE 22717
7 EXTRACTED XBRL INSTANCE DOCUMENT tm218312d1_8k_htm.xml XML 3611
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31918 | Film No.: 21698489
SIC: 2836 Biological Products, (No Diagnostic Substances)